Valion Bio (VBIO.O) and Shear Kershman complete oral mucosal Entolimod formulation milestone

Valion Bio said it successfully formulated oral mucosal Entolimod using Shear Kershman’s BioViscid platform, aiming for needle-free delivery for radiological or nuclear emergencies.